Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity

Drug Metabolism and Disposition

Volumn 28, Issue 7, 2000, Pages 766-771

  Lian Qing, Guo ^a   Fukuda, Katsuyuki ^b   Ohta, Tomihisa ^c   Yamazoe, Yasushi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BERGAMOT OIL; CYTOCHROME P450 3A; FUROCOUMARIN DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TESTOSTERONE;

ARTICLE; CHEMICAL INTERACTION; COMPETITIVE INHIBITION; DRUG HYDROXYLATION; ENZYME ACTIVITY; ENZYME INHIBITION; FRUIT; HUMAN; HUMAN TISSUE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; SUPERNATANT;

CITRUS AURANTIUM; CITRUS SINENSIS; CITRUS X PARADISI; STAPHYLOCOCCUS PHAGE 3A;

EID: 0342868292     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ameer B and Weintraub RA (1997) Drug interactions with grapefruit juice. Clin Pharmacokinet 33:103-121.
2. Bailey DG, Kreeft JH, Munoz C, Freeman DJ and Bend JR (1998a) Grapefruit juice-felodipine interaction: Effect of naringin and 6′,7′-dihydroxybergamottin in humans. Clin Pharmacol Ther 64:248-256.
3. Bailey DG, Malcolm J, Arnold O and Spence JD (1998b) Grapefruit juice-drug interactions. Br J Clin Pharmacol 46:101-110.
4. Bailey DG, Spence JD, Edgar B, Bayliff CD and Arnold JM (1989) Ethanol enhances the hemodynamic effects of felodipine. Clin Invest Med 12:357-362.
5. Bailey DG, Spence JD, Munoz C and Arnold JM (1991) Interaction of citrus juices with felodipine and nifedipine. Lancet 337:268-269.
6. Beier RC (1990) Natural pesticides and bioactive components in foods. Rev Environ Contam Toxicol 113:47-137.
7. Bellevue FH, Woster PM, Edwards DJ, He K and Hollenberg PF (1997) Synthesis and biological evaluation of 6′,7′-dihydroxybergamottin (6,7-Dhb), a naturally occurring inhibitor of cytochrome P450 3a4. Bioorg Med Chem Lett 7:2593-2598.
8. Berhow M, Tisserat B, Kanes K and Vandercook C (1998) Survey of phenolic compounds produced in citrus. Technical Bulletin 1856. U.S. Department of Agriculture, Agricultural Research Service, Peoria, IL.
9. Edwards DJ, Bellevue FH and Woster PM (1996) Identification of 6′,7′-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metab Dispos 24:1287-1290.
10. Edwards DJ, Fitzsimmons ME, Schuetz EG, Yasuda K, Ducharme MP, Warbasse LH, Woster PM, Schuetz JD and Watkins P (1999) 6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther 65:237-244.
11. Fuhr U (1998) Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance. Drug Saf 18:251-272.
12. Fukuda K, Ohta T, Oshima Y, Ohashi N, Yoshikawa M and Yamazoe Y (1997a) Specific CYP3A4 inhibitors in grapefruit juice: Furocoumarin dimers as components of drug interaction. Pharmacogenetics 7:391-396.
13. Fukuda K, Ohta T and Yamazoe Y (1997b) Grapefruit component interacting with rat and human P450 CYP3A: Possible involvement of non-flavonoid components in drug interaction. Biol Pharm Bull 20:560-564.
14. Guo L-Q, Taniguchi M, Xiao Y-Q, Baba K, Ohta T and Yamazoe Y (2000) Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity. Jpn J Pharmacol 82:122-129.
15. He K, Iyer KR, Hayes RN, Sinz MW, Woolf TF and Hollenberg PF (1998) Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem Res Toxicol 11:252-259.
16. Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, Brown MB, Guo W and Watkins PB (1997) Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 99:2545-2553.
17. Morton JF (1987) Grapefruit, in Fruits of Warm Climates (Morton JF ed) pp152-158, (obtained from http://www.hort.purdue.edu/mewcrop/morton/grapefruit.html), Miami, FL.
18. Namba T (1980) Coloured Illustrations of Wakan-Yaku (The Crude Drugs in Japan, China and the Neighbouring Countries). (Japanese, with English indexes) Hoikusha Publishing Co., LTD., Osaka, Japan.
19. Ohta T, Nagahashi M, Miyamoto Y, Hosoi S, Maruyama T, Kiuchi F and Yamazoe Y (1999) Stereostructures of CYP3A4 inhibitors in grapefruit juice. A symposium paper of 41st Symposium on the Chemistry of Natural Products, 1999 Oct 13-15; Nagoya, Japan, pp. 439-444 (with an English abstract).
20. Pathak MA, Daniels F and Fitzpatrick TB (1962) The presently known distribution of furocoumarins (psoralens) in plants. J Invest Dermatol 39:225-239.
21. Runkel M, Bourian M, Tegtmeier M and Legrum W (1997) The character of inhibition of the metabolism of 1,2-benzopyrone (coumarin) by grapefruit juice in human. Eur J Clin Pharmacol 53:265-269.
22. Sanwald P, Blankson EA, Dulery BD, Schoun J, Huebert ND and Dow J (1995) Isocratic high-performance liquid chromatographic method for the separation of testosterone metabolites. J Chromatogr B 672:207-215.
23. Schmiedlin-Ren P, Edwards DJ, Fitzsimmons ME, He K, Lown KS, Woster PM, Rahman A, Thummel KE, Fisher JM, Hollenberg PF and Watkins PB (1997) Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos 25:1228-1233.
24. Scora RW (1975) On the history and origin of citrus. Bull Torrey Bot Club 102:369-375.